Page 125 - 2019_02-Haematologica-web

ASNase hypersensitivities are IgG/IgE dependent
mation during L-asparaginase treatment of children and adults with acute leukemia. Cancer. 1976;37(1):220-228.
17. Fernandez CA, Smith C, Yang W, et al. HLA-DRB1*07:01 is associated with a high- er risk of asparaginase allergies. Blood. 2014;124(8):1266-1276.
18. Fernandez CA, Smith C, Yang W, et al. Genome-wide analysis links NFATC2 with asparaginase hypersensitivity. Blood. 2015;126(1):69-75.
19. Tsujimura Y, Obata K, Mukai K, et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic ana- phylaxis. Immunity. 2008;28(4):581-589.
20. Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol. 2002;109(4):658-668.
21. Fernandez CA, Smith C, Karol SE, et al. Effect of premedications in a murine model of asparaginase hypersensitivity. The Journal of pharmacology and experimental therapeutics. 2015;352(3):541-551.
22. Iwamoto H, Matsubara T, Nakazato Y, Namba K, Takeda Y. Evaluation of the anti- genicity of hydrolyzed cow's milk protein formulas using the mouse basophil activa- tion test. Toxicol Lett. 2016;242:53-59.
23. Iwamoto H, Matsubara T, Nakazato Y, Namba K, Takeda Y. Decreased expression of CD200R3 on mouse basophils as a novel marker for IgG1-mediated anaphylaxis. Immun Inflamm Dis. 2015;3(3):280-288.
24. Liu E, Moriyama H, Abiru N, et al. Anti- peptide autoantibodies and fatal anaphy- laxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. J Clin Invest. 2002;110(7):1021-1027.
25. van der Meer LT, Terry SY, van Ingen Schenau DS, et al. In vivo imaging of antileukemic drug asparaginase reveals a rapid macrophage-mediated clearance from the bone marrow. J Nucl Med. 2017;58(2):214-220.
26. Strait RT, Morris SC, Finkelman FD. IgG- blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-link- ing. J Clin Invest. 2006;116(3):833-841.
27. Wilde DB, Marrack P, Kappler J, Dialynas DP, Fitch FW. Evidence implicating L3T4 in class II MHC antigen reactivity; monoclon- al antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. J Immunol. 1983;131(5):2178-2183.
28. Karnell JL, Dimasi N, Karnell FG, 3rd, et al. CD19 and CD32b differentially regulate human B cell responsiveness. J Immunol. 2014;192(4):1480-1490.
29. Villa A, Santagata S, Bozzi F, et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell. 1998;93(5):885- 896.
30. Bruhns P. Properties of mouse and human IgG receptors and their contribution to dis- ease models. Blood. 2012;119(24):5640- 5649.
31. Caver TE, Slobod KS, Flynn PM, et al. Profound abnormality of the B/T lympho- cyte ratio during chemotherapy for pedi- atric acute lymphoblastic leukemia. Leukemia. 1998;12(4):619-622.
32. Wang B, Hak LJ, Relling MV, Pui CH, Woo MH, Storm MC. ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia. J Immunol Methods 2000;239(1- 2):75-83.
33. van der Sluis IM, Vrooman LM, Pieters R, et al. Consensus expert recommendations for identification and management of asparag- inase hypersensitivity and silent inactiva- tion. Haematologica. 2016;101(3):279-285.
34. Fish SC, Donaldson DD, Goldman SJ, Williams CM, Kasaian MT. IgE generation and mast cell effector function in mice defi- cient in IL-4 and IL-13. J Immunol. 2005;174(12):7716-7724.
35. Stone HD, Jr., DiPiro C, Davis PC, Meyer CF, Wray BB. Hypersensitivity reactions to Escherichia coli-derived polyethylene gly- colated-asparaginase associated with sub- sequent immediate skin test reactivity to E. coli-derived granulocyte colony-stimulat- ing factor. J Allergy Clin Immunol. 1998;101(3):429-431.
36. Hino M, Shimojo N, Ochiai H, et al. Expression of CD203c on basophils as a marker of immunoglobulin E-mediated (L)- asparaginase allergy. Leuk Lymphoma. 2014;55(1):92-96.
37. Beutier H, Gillis CM, Iannascoli B, et al. IgG subclasses determine pathways of ana- phylaxis in mice. J Allergy Clin Immunol. 2017;139(1):269-280.e267.
38. O'Konek JJ, Landers JJ, Janczak KW, et al. Nanoemulsion adjuvant-driven redirection of TH2 immunity inhibits allergic reactions in murine models of peanut allergy. J Allergy Clin Immunol. 2018;141(6):2121- 2131.
39. Walker MT, Green JE, Ferrie RP, Queener AM, Kaplan MH, Cook-Mills JM. Mechanism for initiation of food allergy: dependence on skin barrier mutations and environmental allergen costimulation. J Allergy Clin Immunol. 2018;141(5):1711- 1725.e1719.
40. Kind LS. Fall in rectal temperature as an indication of anaphylactic shock in the mouse. J Immunol. 1955;74(5):387-390.
41. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ. Systemic ana- phylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1- dependent passive anaphylaxis. J Clin Invest. 1997;99(5):901-914.
42. Fulton JD, Harris WE, Craft CE. Hematocrit change as indication of anaphylactic shock in the mouse. Proc Soc Exp Biol Med. 1957;95(4):625-627.
haematologica | 2019; 104(2)
329